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1. Introduction 
There is an increasing concern regarding the widespread use of pesticides and their 
potential impacts on public health. Pesticides differ from other chemical substances because 
they are toxic chemicals deliberately spread into the environment with the aim of 
controlling undesired living species. Since their toxicity may not be completely specific for 
the target organisms, their use may pose a risk to human health. Pesticide poisoning 
remains a serious public health problem worldwide. More than 5 billion pounds of 
pesticides are used annually worldwide, with about 25% being used in the United States (US 
Environmental Protection Agency 2001, 2002). Pesticide exposure occurs during their 
application, via their drainage into water supplies, and through the consumption of food. 
According to the World Health Organization’s estimate, 3 million cases of pesticide 
poisoning occur every year, resulting in more than 250,000 deaths. This number also 
accounts for a substantial fraction of the almost 900,000 people worldwide who die by 
suicide every year. Organo-phosphorus pesticides (OPs) are currently the most commonly 
utilized pesticides in the world, consisting of nearly 40 different chemical members 
registered by the US-EPA (www.epa.gov). About 73 million pounds of OP pesticides were 
used in the United States above in 2001 (70% of all insecticides; Kiely et al.,2004).  
Pesticide poisonings are relatively common in countries such as Sri Lanka, Venezuela, 
Indonesia, South Africa, and Brazil. Among numerous pesticides that can result in death, 
organophosphate insecticides are the most common culprit agents because of their high 
toxicity. In developing countries, in which the use of OP compounds is particularly 
widespread because the hot climatic conditions, the number of deaths may be high. There is 
an increasing concern regarding the widespread use of pesticides and their potential 
impacts on public health. In the United States, a mixture of pesticide residues are detected in  
blood and/or urine of nearly all persons sampled (Barr et al., 2005). During the 1990s some 
2.5–5.0 million agricultural workers were exposed to OPs, which are used as insecticides 
around the world (Abou-Donia, 2003; Das et al., 2001; Farahat et al., 2010; London et al., 
1997). Although OPs are increasingly restricted for use in the US (EPA, 2002), many of the 
pesticides that are no longer available in the US and other developed countries are still 
being produced and used in agricultural or urban applications in developing countries. 
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The mechanism of action of pesticides frequently involves a neurotoxic effect: 
organophosphorous compounds act through the inhibition of central nervous system 
cholinesterase (Jeyaratnam  and Maroni, 1994; Machemer and Pickel, 1994); pyrethroids affect 
the sodium channels of the nerve membrane, keeping them open for more than the few 
milliseconds needed for the generation of the action potential (He, 1994); organochlorinated 
compounds in general act as central nervous system stimulants, but the mechanism of action 
varies for the different active ingredients (Tordoir and Van Sittert, 1994); morpholine 
derivatives alter the balance between excitatory and inhibitory threshold in neurons, impairing 
the function of the nervous system (Barbieri and Ferioli, 1994), while formamidines have an 
agonistic action on the alpha-2 catecholamine receptor (Xue and Loosly,1994).  
Organophosphate (OP) pesticides can produce several distinct neurotoxic effects depending 
on the dose, frequency of exposure, type of OP, and host of other factors that influence 
susceptibility and sensitivity. These effects include acute cholinergic toxicity, a delayed 
ataxia known as organophosphorus ester-induced delayed neurotoxicity (OPIDN), chronic 
neurotoxicity and developmental neurotoxicity. Acute cholinergic syndrome, due to the 
inhibition of ace-tylcholinesterase activity, which occurs within minutes or hours following 
exposure, usually subsides within days or weeks, and plasma or erythocytic 
acetylcholinesterase activity are used for monitoring acute exposure to OP (Lessenger and 
Reese, 1999); Acute OP pesticide exposure can involve wide range of both central and 
peripheral neurologic symptoms. Increased neurologic symptom prevalence may provide 
early evidence of neurologic dysfunctions, before clinically measurable signs are evident. 
Rastogi et al (2010) analyzed the cross-sectional data on neurologic signs and symptoms 
from 225 rural children, both males (n = 132) and females (n = 93) who were occupationally 
and paraoccupationally exposed to methyl OPs (dichlorvos, fenthion, malathion, methyl 
parathion) and ethyl OPs (chlorpyrifos, diazinon, ethyl parathion) as they belonged to 
agricultural families handling, mixing, and spraying the OP pesticides. Among all the 
neurologic self-reported symptoms, headache, watering in eyes, and burning sensation in 
eye/face were the most important clinical manifestations attributed to OP pesticide 
exposure. These symptoms could probably be the consequence of chronic effects of most 
pesticides on the central nervous system. The high frequency of neurologic symptoms 
observed in the study may be due to parasympathetic hyperactivity due to the accumulated 
ACh resulting from AChE inhibition (Rastogi, 2010). 
 Intermediate syndrome, which usually starts 24 to 96 hours after the acute syndrome and is 
characterized by respiratory paresis, weakness, depressed tendon reflexes, and transient 
extrapyramidal symptoms, without response to treatment with the cholinergic receptor 
antagonist atropine (Bhatt et al., 1999; Mileson et al., 1998; Senanayake and Johnson, 1982; 
Shahar and Andraws, 2001); Organophosphate-induced delayed neuropathy, which is a 
symmetric distal neuropathy, usually occurring weeks following an acute exposure 
probably related to the inhibition of the enzyme neuropathy-target esterase present in the 
nervous system (Aiuto et al., 1993). 
Long-term exposure to relatively low levels of OP agents occurs in a variety of 
environments. Pesticides are often applied in a combination with several classes of 
compounds featuring synergistic interactions. One of the neurological functions for which 
an adverse effect of neurotoxic pesticides has been repeatedly hypothesized is behaviour. 
Behaviour is the product of various sensory, motor and associated functions of the nervous 
system, and the hypothesis is that neurotoxic substances can adversely affect one or more of 
these functions, disrupt learning and memory processes, or cause detrimental behavioural 
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effects (IPCS/WHO, 2001). Since behaviour is a very complex system, made of several 
different functions and biochemical activities, it can be studied only based on a very 
complex approach, in which different tests are performed, addressed at a large spectrum of 
functions, in some cases with different approaches for different population subgroups 
(Anger et al., 2000; Cassitto et al., 1990; Fiedler et al., 1996; Krasnegor et al., 1995; Wetherell, 
1996), and conclusion can be drawn only from an integrated evaluation of the available data. 
Because of this complexity, not surprisingly, different approaches have been chosen by 
different researchers, making comparisons between different studies very difficult. 
However, neurobehavioral toxicity is a very important issue for prevention, because some of 
the compounds thought to be involved are largely used in agriculture, and large sections of 
the human population are occupationally and/or environmentally exposed, including 
possible vulnerable subgroups such as children or pregnant women. (Colosio et al, 2009). 
An increasing number of papers have been and are being published on neurobehavioral 
effects of pesticides. However, besides what is well established (e.g. acute effects; OP 
induced delayed polyneuropathy; intermediate syndrome) (Jayawardane et al., 2009; Lotti, 
2001; Lotti and Moretto, 2005), several uncertainties still remain on the real risks for workers 
and consumers of developing neurobehavioral changes after long-term exposures to low 
doses of neurotoxic pesticides (Colosio et al., 2003; Moser, 2007). Experimental data on 
neurotoxicological outcomes in animals are abundant, but relatively few are those studies 
dealing with long-term exposures (for a review see Moser, 2007). In fact, most reports in the 
literature deal with repeated exposures to pesticides, mainly OPs, as short as five days and 
rarely longer than three months. In addition, an even lower number of studies assessed 
neurobehavioral performance days or weeks after end of exposure.  
In southern Brazil, agricultural workers involved in tobacco plantation use a combination of 
OP (chlorpyrifos and acephate), herbicides (glyphosate and clomazone), plant growth 
regulators (flumetralin), fungicides (iprodione), and insecticides (imidacloprid). Exposure to 
OP is known to induce clinical syndromes and biochemical alterations in humans. Besides 
acute cholinergic symptoms, which are related to the inhibition of acetylcholinesterase 
activity, acute or chronic OP exposure can also induce delayed toxic and behavioral effects 
not clearly related to the inhibition of esterases (Brown and Brix, 1998; Jamal, 1997; Mileson 
et al., 1998; Peter and Cherian, 2000; Sudakin et al., 2000). Most of the actions of OP on the 
nervous system seem to be related to organophosphorylation of protein targets, as 
acetylcholinesterase and neuropathy target esterase, or directly to binding of OP to nicotinic 
receptors (Mileson et al., 1998). 
Chronic organophosphate-induced neuropsychiatric disorders (COPIND) are a less well-
characterized syndrome in chronic OP poisoning. COPIND may be caused by chronic low-
level exposure to OP, without cholinergic symptoms (Ray and Richards, 2001). The 
underlying mechanisms are not established, but are not dependent on inhibition of esterases 
(Levin et al., 1976) The most common clinical symptoms include impairment in memory, 
concentration, and learning; anxiety, depression, psychotic symptoms, chronic fatigue, 
peripheral neuropathy, autonomic dysfunction and extrapyramidal symptoms such as 
dystonia, resting tremor, bradikynesia, postural instability and rigidity of face muscles; and 
nonresponsiveness to levodopa treatment. Regarding psychiatric symptoms, 
neurobehavioral effects of low-level pesticide exposure have not been extensively studied 
with standardized, quantitative neuropsychologic batteries.  
OPs do not accumulate in living organisms and the acute signs and symptoms disappear as 
the AChE activity returns to normal level. Therefore, they are regarded as relatively safe. 
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However, as some literature data suggest, after either acute or prolonged exposure to OPs 
subtle neurobehavioral impairments may persist long after normalization of AChE activity. 
The possibility that OPs exposure may induce such long-term effects is nowadays a problem 
of great concern for the regulatory agencies. Rodnitzky et  al, (1975) and Durham et  al,  
(1965) in their  cross-sectional epidemiologic studies using neurobehavioral  tests have 
suggested that subtle behavioural impairments among pest control workers, farmers, and 
manufacturing workers are related to low level pesticide exposure or are persistent effects of  
severe acute pesticide poisoning (Metcalf and Holmes,  1969; Burkhart et al,  1978; Korsak 
and Sato,  1977; Levin et al, 1976; Xintaras et al, 1978; Savage et al, 1983, reviewed by; 
Johnson and Anger,  1983).  There are also numerous case reports  and  case registries  
indicating that  4-9%  of  individuals  with  acute organophosphate  poisoning experience  
delayed or persistent neuropsychiatric effects, including depression, weakness, nervousness, 
irritability, fatigue, insomnia,  forget fulness, confusion, and schizoid and depressive  
reactions (Gershon and Shaw, 1961). Behavioural impairments due to pesticide exposure 
have also been implicated in serious accidents among agricultural workers (Redhead, 1968; 
Wood et al, 1971; Smith et al, 1968). 
Amr et al. (1997) found that, compared to controls, subjects heavily exposed to pesticides (40 
h/week, 9 months/year) had a significant increase in the frequency of psychiatric disorders, 
especially depressive neurosis and dysthymic disorder (DSM-III-R). These results left 
unresolved issue of reversibility of psychiatric symptoms after a pesticide-free period and 
the occurrence of syndrome in subjects not so heavily exposed to OP compounds. Another 
confounding factor in these studies has been the exposures to several types of pesticides  
which has been shown to reproduce features of Parkinson’s disease (Binukumar et al, 2010). 
Some of  the factors which  have been  shown to  influence the  feasibility of  an 
epidemiologic appraisal of CNS abnormalities among pesticide workers depend upon: 1)  
the  extent to which  exposure can  be  quantified; 2)  the multiplicity  of  chemical 
exposures;  3)  the  sensitivity and  specificity of  the neurobehavioral test; and 4)  the time 
taken  to  conduct  the  test. Stephens, et al (1995) studied the relationship between chronic 
(nonreversing) neuropsychological effects and acute exposure effects and investigated 77 
organophosphate-exposed male sheep-dippers. Acute exposure effects were assessed 
prospectively using a purpose-constructed symptoms questionnaire administered pre-, and 
24 h post exposure. Urine was analysed for dialkylphosphate levels to confirm recent 
exposure. Chronic effects were assessed in a cross-sectional neuropsychological study in the 
absence of recent exposure using computerized neuropsychological tests, the General 
Health Questionnaire, and the subjective Memory Questionnaire. Simple correlation and 
multiple linear regression analyses, were used to assess relationships between the changes 
in total symptoms reporting from baseline to 24 h after exposure and chronic effect 
outcomes. There was no evidence of any association between reported symptom levels and 
chronic neuropsychological effects. This suggests that chronic effects of OP exposure appear 
to occur independently of symptoms that might immediately follow acute OP exposure. 
This has implications for exposure control: individuals may experience chronic effects 
without the benefit of earlier warning signs of toxic effects during acute exposures.  
Military personnel returning from the Gulf War (GW) have reported symptoms that have 
not only diagnosis using known disease entities but also do not appear to occur in a 
predictable constellation that can be classified as a single syndrome (Persian Gulf Veterans 
Coordinating Board, 1995; Institute of Medicine, 1996; Iowa Persian Gulf Study Group, 1997; 
Proctor et al., 1998; Wolfe et al., 1998). However, prominent among complaints reported by a 
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high percentage of several samples of GW veterans are symptoms that suggest dysfunction 
in the central nervous system (CNS). These include memory loss, concentration problems, 
headaches, and fatigue. Freya Kame et al (2005) analyzed cross-sectional data from 18,782 
white male licensed private pesticide applicators enrolled in the Agricultural Health Study 
in 1993–1997. Applicators provided information on lifetime pesticide use and 23 neurologic 
symptoms typically associated with pesticide intoxication. Among chemical classes of 
insecticides, associations were strongest for organophosphates and organochlorines. 
Associations with cumulative exposure persisted after excluding individuals who had a 
history of pesticide poisoning or had experienced an event involving high personal pesticide 
exposure. These results suggest that self-reported neurologic symptoms are associated with 
cumulative exposure to moderate levels of fumigants and organophosphate and 
organochlorine insecticides, regardless of recent exposure or history of poisoning.  
2. Behavioural studies in animals 
Chronic exposure of rats to one tenth of the LC50 of sarin for 30 days induced a decrease in 
M1 receptors in the olfactory tubercle, changes in blood and brain ChE activities and the 
expression of cytokines mRNA levels (Henderson et al., 2002). Guinea pigs receiving 0.3, 0.4 
or 0.5×LD50 of repeated sarin injections exhibited disrupted sleep pattern in the EEG (Shih 
et al., 2006) and a decrease in red blood cell AChE to a low level of baseline. Obvious signs 
of cholinergic toxicity were observed only in animals receiving sarin. Experiments involving 
the application of multiple low-doses of soman induced alterations in long-term 
potentiation (Armstrong et al., 1997). We also reported dichlorvos administration caused a 
marked decrease in both the ambulatory and stereotypic components of spontaneous 
locomotor activity of rats. The muscle strength and coordination of the dichlorvos-treated 
animals was also significantly impaired. Besides, a marked deterioration in the memory 
function assessed in terms of the conditioned avoidance response was discernible at the end 
of the treatment schedule in the experimental animals (Sarin and Gill KD, 1998). In a series 
of experiments Gralewicz and Soćko (1997) have demonstrated that exposures to 2-chloro-1-
(2,4-dichlorophenyl) vinyl diethyl phosphate (CVP) in rabbit resulted in a similar inhibition 
of blood AChE activity but the effect of the second exposure on body temperature and 
hippocampal EEG was smaller and less consistent than that of the first one. This would 
indicate that some permanent changes within the CNS may occur even after a single 
exposure to CVP. They also studied the CVP exposure in rat. One injection/day for ten days 
at a symptomatic (3.0 mg/kg) dose inhibiting blood and brain AChE activity by about 80%, 
the tolerance to CVP, assessed from the spontaneous locomotor behaviour, developed 
within four to five days. However, single exposure to CVP at a symptomatic (3.0 mg/kg) or 
subsymptomatic (1.0 mg/kg, less than 50% AChE inhibition) dose, or repeated exposure 
(one injection/day, for ten days) at subsymptomatic doses (1.0 mg/kg or 0.5 mg/kg) 
resulted in subtle changes in complex behaviours detectable after AChE activity in blood 
and in the brain had returned to the normal level. The changes neophobia in the open field, 
an increased and more persistent emotional response to a stressful stimulus, and increased 
EEG arousal response to an external pain signalling stimulus suggest an increased reactivity 
of the system or systems responsible for the induction of fear. Direct intrahypothalamic 
injections of CVP, unlike those of oxotremorine, a direct stimulant of cholinergic muscarinic 
receptors, did not induce overt changes in the animal (rabbit) behaviour and EEG. This 
would indicate that the changes in the CNS functions after CVP exposure may be the 
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consequence of increased cholinergic activity due to AChE inhibition rather than to a direct 
stimulation of cholinergic muscarinic receptors by CVP. The above findings provide 
experimental evidence that health effects of exposure to CVP, may persist after recovery of 
AChE activity in blood and in the brain. (Gralewicz and Soćko ,1997).  
Alvin et al (2007) have demonstrated that rats when injected with CPF subcutaneously (dose 
range, 2.5-18.0 mg/kg) every other day over the course of 30 days, and then given a two 
week, CPF-free washout period, dose dependent decrements in a water maze hidden 
platform task and a prepulse inhibition procedure were observed during the washout 
period, without significant effects on open field activity, rotarod performance, grip strength, 
or a spontaneous novel object recognition task. After washout, levels of CPF and its 
metabolite 3,5,6-trichloro-2-pyridinol (TCP) were minimal in plasma and brain, however, 
cholinesterase inhibition was still detectible. Further, the 18.0 mg/kg dose of CPF was 
associated with (brain region-dependent) decreases in nerve growth factor receptors and 
cholinergic proteins including the vesicular acetylcholine transporter, the high affinity 
choline transporter, and the nicotinic acetylcholine receptor. These deficits were 
accompanied by decrease in anterograde and retrograde axonal transport measured in 
sciatic nerves exvivo. Thus, low-level (intermittent) exposure to CPF has persistent effects 
on neurotrophin receptors and cholinergic proteins, possibly through inhibition of fast 
axonal transport. Such neurochemical changes may lead to deficits in information 
processing and cognitive function. We report that (Binkumar et al, 2010), chronic OP 
(dichlorvos) exposure (2.50 mg/kg b.wt.s.c/daily for 12 weeks) can also caused nigrostriatal 
dopaminergic degeneration. The degenerative changes were accompanied by a loss of 60-
80% of the nigral dopamine neurons and 60-70% reduction in striatal dopamine and tyrosine 
hydroxylase levels. Dichlorvos exposed animals also showed α-synuclein and ubiquitin 
positive inclusions along with swollen, dystrophic neurites and mitochondrial abnormalities 
like decreased complex I&IV activities, increased mitochondrial size, axonal degeneration 
and presence of electron dense perinuclear cytoplasmic inclusions in the substantia nigra of 
rats. These animals also showed evidence of oxidative stress, including increased 
mitochondrial ROS levels, decreased MnSOD activity and increased lipid peroxidation. 
Measurable impairments in neurobehavioral indices were also observed. Notable 
exacerbations in motor impairments, open field and catalepsy were also evident in 
dichlorvos exposed animals. All these findings taken together indicate that chronic 
dichlorvos (OP) exposure may cause nigrostaital neurodegenaration and significant 
behavioral impairments. Phenytoin (PHT) exposure  in utero of rats demonstrate abnormal 
circling, decreased learning, hyperactivity, and delayed air righting reflex development. The 
effects of prenatal PHT on offspring learning have been found on multiple-T mazes and on 
spatial navigation (Morris maze). PHT-exposed offspring showed increased preweaning 
mortality, growth reduction, and abnormal circling. PHT noncircling offspring 
demonstrated impaired reference memory-based spatial learning (acquisition and reversal), 
but no other effects. By contrast, PHT circling offspring demonstrated not only impaired 
reference memory-based spatial learning, but also impaired cued platform learning, 
impaired spatial discrimination, and impaired working memory-based learning. These data 
confirm that prenatal PHT induces a specific reference memory-based spatial learning 
deficit even in asymptomatic (noncircling) offspring that is distinct from the impairment 
induced in littermates exhibiting the circling impairment. Recently we reported that chronic 
OP exposure (dichlorvos) may lead to significant increase in mitochondrial Ca2+ uptake. 
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Our results also indicated decreased mitochondrial electron transfer activities of cytochrome 
oxidase (complex IV) along with altered mitochondrial complex I, and complex II activity, 
which might have resulted from elevated mitochondrial calcium uptake. The alterations in 
the mitochondrial calcium uptake and mitochondrial electron transfer enzyme activities in 
turn might have caused an increase in malondialdehyde, protein carbonyl and 8-
hydoxydeoxyguanosine formation as a result of enhanced lipid peroxidation, and as well as 
protein and mtDNA oxidation. All this could have been because of enhanced oxidative 
stress, decreased GSH levels and also decreased Mn-SOD activity in the mitochondria 
isolated from dichlorvos treated rat brain. Thus, chronic organophosphate exposure has the 
potential to disrupt cellular antioxidant defense system which in turn triggers the release of 
cytochrome c from mitochondria to cytosol as well as caspase-3 activation in dichlorvos 
treated rat brain  Low-level long-term organophosphate exposure finally resulted in 
oligonucleosomal DNA fragmentation, a hallmark of apoptosis. These studies provide an 
evidence of impaired mitochondrial bioenergetics and apoptotic neuronal degeneration 
after chronic low-level exposure to OPs that affect the behavioural impairement (Kaur et al., 
2007). OPs can also modulate intracellular signaling pathways downstream of receptors and 
suggests that the diverse neurotoxic effects of many Ops may reflect their influence on 
multiple intracellular signaling pathways. Functional studies examining the effects of OPs 
on signaling events downstream of muscarinic receptor activation further support the 
hypothesis that OPs can interact directly with M2 receptors (Verma et al., 2008). A 
comparative study of paraoxon, malaoxon, and chlorpyrifos oxon in slice cultures of rat 
frontal cortex indicated that all three OPs inhibited cAMP formation in a concentration 
dependent manner (Ward and Mundy., 1996). Chlorpyrifos-oxon was also found to inhibit 
c-AMP synthesis in striatal dissociated cells (Huff et al., 1994).   
Numerous studies have indicated that CREB is critical to several forms of use-dependent 
synaptic plasticity and transcription-dependent forms of memory, and evidence supports a 
major role for CREB in cell survival and differentiation during brain development. Since 
impairments of brain development and memory function are two primary neurological 
effects observed in laboratory studies with OPs, Schuh et al., (2002) hypothesized that the 
mechanisms underlying these effects may include alteration of the expression or activational 
status of CREB. Verma et al.,(2008) reported dichlorvos at low dose exposure, leads to 
reduction in the signal transduction cascade linked to receptor subtypes and adenylyl 
cyclase-linked signaling pathway was impaired. Finally, the phosphorylation of CREB, was 
significantly reduced in both low dose and high dose group animals. These reveal the 
significance of M2 muscarinic receptor linked adenylyl cyclase signaling pathway and 
phosphorylation of CREB in the development of neurobehavioral impairments after chronic 
low-level exposure to dichlorvos. 
3. Developmental toxicity 
Although some organophosphates are undergoing increasing scrutiny and restriction (U.S. 
Environmental Protection Agency (EPA) 2000, 2002) because of their propensity to elicit 
developmental neurotoxicity ( Casida and Quistad2004; Landrigan 2001; Slotkin 2004), these 
compounds nevertheless still comprise 50% of all insecticide use worldwide, and exposure 
of the human population continues to be nearly ubiquitous (Casida and Quistad 2004). 
Originally, it was thought that the adverse effects on brain development reflected the same 
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basic mechanism that underlies systemic toxicity, namely, cholinesterase inhibition and 
consequent cholinergic hyperstimulation (Pope 1999). However, evidence accumulating 
over the past decade implicates a host of other mechanisms that depend instead upon the 
direct targeting of events specific to the developing brain (Barone et al. 2000; Pope 1999; Rice 
and Barone 2000; Slotkin 2004). Levels of pesticides detected in amniotic fluid demonstrate 
that the foetus has direct exposure to at least some pesticides during development 
(Bradman2003). Chlorpyrifos, the most-studied organophosphate, has been shown to 
disrupt the basic cellular machinery that controls the patterns of neural cell maturation and 
the formation and activity of synapses, exclusive of the effects on cholinesterase, which are 
mediated instead by its metabolite, chlorpyrifos oxon (Barone et al. 2000; Casida and 
Quistad 2004; Gupta 2004; Pope 1999; Qiao et al. 2002, 2003; Yanai et al. 2002). These 
mechanisms are likely to be shared by other organophosphates, but these have not been 
evaluated in detail (Abu-Qare and Abou-Donia 2001; Pope 1999; Qiao et al. 2001; Slotkin 
1999, 2004; Whyatt et al. 2002). Chlorpyrifos exposure during the perinatal period is known 
to evoke deficits in neuritic outgrowth, specifically including the targeting of cholinergic 
projections (Howard et al. 2005; Qiao et al. 2002, 2003; Slotkin et al. 2001). Nevertheless, 
(Dam et al.1999), as early as 1 day after neonatal chlorpyrifos exposure, there is a shortfall in 
ChAT, the constitutive marker of cholinergic projections (Dam et al.1999). The initial deficits 
in the development of cholinergic projections lead to the subsequent emergence of 
abnormalities of cholinergic innervation. Substantial deficits in cholinergic synaptic activity, 
and related behavioral anomalies in adolescence and adulthood (2001; Slotkin 1999,2001, 
2004; Slotkin et al. 2001). 
Young animals are far more susceptible than adults to organophosphate-induced growth 
inhibition and lethality, there is a wide range over which disparate compounds elicit such 
effects. For example, parathion is far more systemically toxic to newborn rats than is 
chlorpyrifos, in part reflecting pharmacokinetic differences centering around the ontogeny 
of enzymes activating the parent compounds to the corresponding oxons, compared with 
the enzymes that break down the oxons to inactive metabolites (Atterberry et al. 1997; 
Padilla et al. 2000, 2004). The maximum tolerated doses of each agent correspond closely to 
the relative potencies toward cholinesterase inhibition and to the rate of recovery of 
cholinesterase activity, thus drawing a direct mechanistic connection of cholinergic 
hyperstimulation to overall systemic toxicity (Pope and Chakraborti 1992; Pope et al. 1991; 
Tang et al. 2003). In contrast, in vitro evaluations that bypass the pharmacokinetic 
differences suggest that chlorpyrifos is more potent toward inhibition of cell membrane 
function (Barber et al. 2001) and for eliciting cytotoxicity in immature neurons and glia 
(Monnet-Tschudi et al. 2000), despite the fact that parathion elicits greater cholinesterase 
inhibition (Zurich et al. 2000); indeed, physostigmine, a nonorganophosphate cholinesterase 
inhibitor, is far less effective in disrupting neural cell development in vitro, even at 
concentrations that completely block cholinesterase (Qiao et al. 2001). Theodore et al, (2006) 
studied the neuritic outgrowth and cholinergic synaptic development in neonatal rats. They 
have given different organophosphates (chlorpyrifos, diazinon, parathion) at doses 
spanning the threshold for impaired growth and viability. The result indicated that 
Parathion (maximum tolerated dose, 0.1 mg/kg) was far more systemically toxic than was 
chlorpyrifos or diazinon (maximum tolerated dose, 1–5 mg/kg). Below the maximum 
tolerated dose, diazinon impaired neuritic outgrowth in the forebrain and brainstem, 
evidenced by a deficit in the ratio of membrane protein to total protein. Diazinon also 
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decreased choline acetyltransferase activity, whereas it did not affect hemicholinium-3 
binding to the presynaptic choline transporter, an index of cholinergic neuronal activity. 
These results indicate a complete dichotomy between the systemic toxicity of 
organophosphates and their propensity to elicit developmental neurotoxicity.  
Brenda Eskenazi et al (2007) investigated the relationship of prenatal and child OP urinary 
metabolite levels with children’s neurodevelopment. Their result indicated, 
dialkylphosphate (DAP) levels were negatively associated with Mental Development ( 
MDI), but child measures were positively associated. At 24 months of age, these associations 
reached statistical significance. Neither prenatal nor child DAPs were associated with Child 
Behavior Checklist (CBCL) attention problems, but both prenatal and postnatal DAPs were 
associated with risk of pervasive developmental disorder. Their report revealed adverse 
associations of prenatal DAPs with mental development and pervasive developmental 
problems at 24 months of age. Results should be interpreted with caution given the 
observed positive relationship with postnatal DAPs. Raul Harari et al (2010), studied 
Northern Ecuador population, where floriculture is intensive and relies on female 
employment, they carried out an intensive cross-sectional study to assess children’s 
neurobehavioral functions at 6–8 years of age. They examined all 87 children attending two 
grades in the local public school with an expanded battery of neurobehavioral tests. 
Information on pesticide exposure during the index pregnancy was obtained from maternal 
interview. The children’s current pesticide exposure was assessed from the urinary 
excretion of organophosphate metabolites and erythrocyte acetylcholine esterase activity. 
Their findings support the notion that prenatal exposure to pesticides at levels not 
producing adverse health outcomes in the mother can cause lasting adverse effects on brain 
development in children. Pesticide exposure therefore may contribute to a “silent 
pandemic” of developmental neurotoxicity (Raul Harari et al ,2010). 
4. Role of paraoxonase in OP detoxication 
In 1946, Abraham Mazur was the first to report the presence of an enzyme in animal tissue 
which was able to hydrolyse organophosphate compounds (Mazur,1946). This led to the 
initial identification of the human serum paraoxonase (PON1) enzyme in the early 1950s 
(Aldridge,1951a, Aldridge,1951b). PON1 was named after its ability to hydrolyse the 
organophosphate substrate paraoxon (paraoxonase activity, EC 3.1.8.1), which is the toxic 
metabolite of the insecticide parathion. Because PON1 could also hydrolyse aromatic esters, 
such as phenylacetate (arylesterase activity, EC 3.1.1.2), the term ‘A-esterase’ was introduced 
for the enzyme hydrolysing both compounds. This led to much discussion during the 
following years as to whether one enzyme or two were responsible for the paraoxonase and 
arylesterase activity,( La Du ,2002) but finally, conclusive evidence was delivered that both 
paraoxonase activity and arylesterase activity were properties of PON1. (Sorenson 1995) 
When Mackness and colleagues demonstrated that PON1 could prevent the accumulation of 
lipoperoxides in low-density lipoprotein (LDL) (Mackness,1991)  thus linking PON1 to 
cardiovascular disease, the scientific interest in PON1 increased immensely. Despite the 
boom in research, to date the exact physiological function of PON1 is still unclear. 
PON1 belongs to a family of serum paraoxonases, consisting of PON1, PON2 and PON3. 
The genes coding for these enzymes are all located next to each other on the long arm of 
chromosome (Primo-Parmo ,1996) (7q21.3-q22.1)7. PON1 and PON3 are expressed in the 
liver and excreted in the blood where they are associated with the high-density lipoprotein 
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(HDL) particle( Reddy ,2001).  PON2 is not present in blood, but is expressed widely in a 
number of tissues, including the liver, lungs, brain and heart (Mochizuki 1998). Of the 
paraoxonase family, PON1 is the most investigated and best understood member. While it 
was assumed that high levels of PON1 would protect against exposure to specific OP 
compounds, only a single experiment that directly addressed this question had been 
reported prior to 1990. Main (1956) reported that injection of partially purified PON1 into 
rats increased their resistance to paraoxon. This observation was confirmed and extended 
through a series of experiments begun in costa et al laboratory in 1990. Injection of purified 
rabbit paraoxonase into rats increased their resistance to paraoxon exposure (Costa et al., 
1990). Injection of purified rabbit PON1 into mice 4 h prior to exposure dramatically 
increased their resistance to chlorpyrifos oxon (Li et al., 1993). An increase in resistance to 
the parent compound, chlorpyrifos, was also observed (Li et al., 1995). These experiments 
demonstrated clearly that high levels of plasma paraoxonase could protect against exposure 
to chlorpyrifos oxon or chlorpyrifos. Protection was also observed when purified rabbit 
PON1 was injected post-exposure or 24 h prior to exposure, indicating that administration 
of purified or recombinant PON1 would be useful for ameliorating or even preventing 
adverse consequences of exposure to OP compounds. Whereas higher PON1 levels were 
demonstrated clearly to be protective, determining whether low levels of PON1 would 
result in greater sensitivity was not possible until the development of PON1knockout mice, 
generated by Drs. Jake Lusis, Diana Shih and co-workers (Shih et al., 1998). Knocking out 
the mouse PON1 gene resulted in a dramatic increase in sensitivity to chlorpyrifos oxon 
exposure and a modest increase in sensitivity to chlorpyrifos exposure, as assessed by 
measuring brain cholinesterase inhibition. Dermal exposures to levels of chlorpyrifos oxon 
that produced no symptoms of cholinergic effects and minimal inhibition of brain 
cholinesterase in wild-type mice were unexpectedly lethal to the PON1 null mice. Similar 
results were observed when the knockout mice were exposed to diazoxon (Li et al., 2000). 
Dermal exposure to 2 or 4 mg/kg diazoxon produced no measurable effect in wild-type 
mice, but was lethal to the PON1 knockout mice, and exposure to 1 mg/kg diazoxon had 
significant adverse effects in the knockout mice without measurably affecting the wild-type 
mice. Hemizygous mice, with only one PON1 allele, exhibited intermediate sensitivity. 
Exposure of the PON1 knockout mice to paraoxon, however, produced an unexpected and 
initially puzzling result. They were not anymore sensitive than wild-type mice to paraoxon 
exposure. Further experiments demonstrated that resistance of the PON1 knockout mice to 
diazoxon was restored by injection of purified PON1R192 or PONQ192 alloforms, with 
either alloform providing equivalent protection (Li et al., 2000). Resistance to chlorpyrifos 
oxon was also restored; however, the PON1R192 alloform provided significantly better 
protection that did the PON1Q192 alloform. Neither alloform provided protection against 
paraoxon exposure. While there was some protection afforded by PON1 against the 
respective parent compounds, the protective effects of PON1 were most striking with the 
oxonforms of chlorpyrifos and diazinon. The parent OP compound is converted to its more 
toxic oxon form in the liver, by cytochrome P450-mediated oxidative desulfuration, and the 
oxon form serves as the direct substrate for PON1. Since chlorpyrifos oxon inhibits 
acetylcholinesterase at least 1000 times more rapidly than chlorpyrifos (Huff et al., 1994), 
even a small percentage of oxon content is important with respect to an individual’s PON1 
status  
Multiple investigators have examined the potential role of polymorphisms in veterans with 
unexplained illness, but the results have been mixed (Haley et al1999). Haley et al (1999) 
www.intechopen.com
Chronic Exposure to Pesticides- Neurological, 
Neurobehavioral and Molecular Targets of Neurotoxicity 13 
reported that the most severely symptomatic GW veterans exhibited particularly low 
activity of paraoxonase (PON1) type Q, the type that would be most active in neutralizing 
nerve gases. Mackness et al, (2000) found that veteran’s decreased capacity to metabolize OP 
chemicals might have contributed to their likelihood of developing GW illness. Hotoph et al 
(2003) found that PON1 activity, which is a major determinant of OP toxicity in human, was 
significantly decreased in British veterans deployed to the GW compared to nondeployed 
veterans. The PON1 gene presents several polymorphisms in the coding and promoter 
regions that affect the catalytic efficiency of the enzyme toward different substrates (the 
Q192R polymorphism) and its level of expression (e.g., the C-108T polymorphism). 
Extensive research in transgenic animal models clearly indicates that PON1 ‘‘status’’, 
encompassing both the Q192R polymorphism and the level of PON activity, plays a most 
relevant role in modulating the acute toxicity of some, but not all OPs. The important 
determinant is the catalytic efficiency of each PON1 allozyme toward a specific substrate; 
thus, in case of chlorpyrifos oxon, PON1 provides protection in vivo, and PON1R192 
provides better protection than PON1Q192; in case of diazoxon, both alloforms provide the 
same degree of protection, while in case of paraoxon, the substrate after which the enzyme 
was named, PON1 does not provide any protection due to an overall low catalytic efficiency 
of PON1 toward this substrate. These studies in transgenic mice provide a convincing case 
of extrapolating the results obtained in animals to humans; however, direct and conclusive 
confirmation of the relevance of PON1 status in determining relative susceptibility to OP 
toxicity is still lacking. 
5. Conclusions 
This chapter covers the background information and the epidemiological evidence, on 
exposures of people and different experimental animals to pesticide and the consequences 
in regard to the neurodegeneration, neurodevelopment and neurobehavioral impairments. 
The fact that different studies provide equivocal results on the functions affected, together 
with the fact that the observed changes are usually very high, and do appear to be 
correlated with overt nervous system impairment, suggest that the neurobehavioural impact 
of low level prolonged exposure to pesticides. In addition to that pesticide exposure also 
affects the offspring, and consistent neurobehavioral impairments were also reported.  The 
evidence suffers from a variety of shortcomings and sources of imprecision. These problems 
would tend to cause an underestimation of the true extent of the risks. The overall 
experimental and epidemiological evidence suggests that the substantial vulnerability of the 
mature and developing nervous system to low concentrations of pesticides should lead to a 
strengthened emphasis on protection of workers and general people who handle the 
pesticides that may cause harm to the nervous system. For both toxicologic and 
epidemiologic reasons, it is essential that the neurobehavioral potential of low-level, chronic 
exposure to pesticides and pesticide mixtures be ascertained. The available evidence 
suggests there is a high probability for subtle adverse health effects. Workers exposed to 
pesticides are one of the largest occupational risk groups in the world.  The effects of these 
occupational exposures on worker’s nervous systems and behaviour are just beginning to be 
studied. A precautionary principle in regard to neuronal toxicity should be applied in 
occupational health, and this issue should also attract more research, preferably with a focus 
on exposure assessment and valid outcome measures in prospective study designs.  
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PON1 status plays an important role in protecting against exposures to diazinon and 
chlorpyrifos, particularly to the oxon residues present in these exposures. The most 
important conclusion to come from studies is that to understand the role that PON1 plays in 
an individual’s sensitivity or resistance to a given exposure or in the pharmacokinetic 
disposition of a specific drug, it is important to know both the levels of PON1 and it’s 
genetic polymorphism. This too is expected to be a fruitful area of future research. In 
conclusion, we found that prevalence of neurologic symptoms was associated with exposure 
to pesticides. These associations were present in individuals with no history of pesticide 
poisoning or high exposure events and were independent of recent exposure. Thus, they are 
likely due to chronic moderate exposure. Although the neurotoxicity of high-level exposure 
is accepted, more attention to the risks associated with moderate low level exposure may be 
required.  Research is needed to improve our understanding of the mechanisms involved 
and help in identifying the best means of protecting future generations against a silent 
pandemic of neurotoxicity. 
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